Press Releases - Great Lakes NeuroTechnologies

Great Lakes NeuroTechnologies To Be Awarded A Patent For Objectively Training And Adjusting DBS Systems With The Ability To Capture Patient-Specific Brain Signals

Great Lakes NeuroTechnologies To Be Awarded Four Patents For Movement Disorder Monitoring And Therapy Adjustment

Great Lakes NeuroTechnologies Receives Two New NIH SBIR Grant Awards

Great Lakes NeuroTechnologies Allowed Patent Claims Covering Therapy And Diagnostic Device Combinations

Great Lakes NeuroTechnologies Introduces KinesiaU™ For Objective Motor Assessment Using A Smartwatch

Great Lakes NeuroTechnologies Awarded Two New Patents For Movement Disorders Therapy Adjustment

Great Lakes NeuroTechnologies Wins Patent On Using Cell Phones And Smart Watches To Help Treat Parkinson’s Disease

Great Lakes NeuroTechnologies Expands Patent Portfolio

Great Lakes NeuroTechnologies Receives Two Deep Brain Stimulation Programming Patents

Great Lakes NeuroTechnologies Awarded Deep Brain Stimulation Programming Patent

Great Lakes NeuroTech To Collaborate With UCB On Wearables And Data Visualization Tools To Help Improve Patient Experiences For People With Parkinson’s Disease

WEARABLE TECHNOLOGY IN PARKINSON’S DISEASE DEMONSTRATES INCREASED REFERRAL RATE FOR ADVANCED THERAPY

GREAT LAKES NEUROTECH VALIDATION STUDIES ON WEARABLE TECH FOR PARKINSON’S TO BE HIGHLIGHTED AT MOVEMENT DISORDER SOCIETY ANNUAL MEETING IN BERLIN

GREAT LAKES NEUROTECH ISSUED 4 PATENTS COVERING WEARABLES FOR MEASURING SYMPTOMS, ADJUSTING THERAPIES, AND DATABASE LEARNING IN PARKINSON’S DISEASE

Automated Telehealth Diagnostics For Remote Parkinson Monitoring.

Great Lakes NeuroTech Allowed Patent Claims For Deep Brain Stimulation Visualization Maps

Great Lakes NeuroTech Secures $1.9M For Closed-Loop Programming Of Deep Brain Stimulation In Parkinson’s With Wearable Sensors

Wearables And Apps For Parkinson’s Disease: Why Big Data And Big Names May Not Be Small Enough

PRESS RELEASE: Great Lakes NeuroTech Pilot Studies Demonstrate Computer Guided Algorithms For Programming Deep Brain Stimulation In Parkinson’s Disease

PRESS RELEASE: Great Lakes NeuroTech Enters Medical Device App Market With Kinesia One For Monitoring Parkinson’s Disease

Great Lakes NeuroTechnologies Uses IoT To Improve Diagnostics And Care For Parkinson’s Disease Patients

PRESS RELEASE: $1.5M NIH Funding To Expand Parkinson’s Telemedicine To Mobile Apps

PRESS RELEASE: Great Lakes NeuroTechnologies Continues Intellectual Property Growth As New Patent Claims Focus On Parkinson’s Device Accuracy And Sensitivity

PRESS RELEASE: Scholarships From GLNT To Support Biomedical Engineering Education For Northeast Ohio Students

PRESS RELEASE: GLNT Secures Allowance Of Patent For Controlling Parkinson’s Therapy In Response To Symptoms

PRESS RELEASE: Great Lakes NeuroTechnologies Launches Study To Automatically Classify Abnormal Muscle Tone In Movement Disorders

PRESS RELEASE: GLNT Awarded Patent For Sensor Based Continuous Parkinson’s Assessment During Daily Activities

PRESS RELEASE: GLNT Expanding Telemedicine Technology For Parkinson’s Disease

PRESS RELEASE: GLNT Awarded Patent For Technology To Treat Parkinson’s Disease With Brain Stimulation During Sleep

PRESS RELEASE: Kinesia ProView Launches To Visualize Parkinson’s Symptom Response To Deep Brain Stimulation Programming

PRESS RELEASE: Great Lakes NeuroTechnologies Secures $1.7 Million To Develop Continuous Dyskinesia Monitoring Technology For Parkinson’s Disease

PRESS RELEASE: Great Lakes NeuroTechnologies Launches Study To Develop Intelligent Algorithms For Programming Deep Brain Stimulation In Parkinson’s

PRESS RELEASE: Great Lakes NeuroTechnologies’ Kinesia Technology Receives TGA Approval For Parkinson’s Assessment In Australia

PRESS RELEASE: GLNT Receives $1.5 Million To Further Technology For Assessing Bradykinesia Response To Novel Therapies In Parkinson’s Disease

PRESS RELEASE: GLNT Launches Parkinson’s Technology In Europe For Quantitative Assessments In Telemedicine

PRESS RELEASE: GLNT Issued Patent Claims For Technology To Assess Parkinson’s Disease

PRESS RELEASE: GLNT Secures Over $4.5 Million In Funding To Fuel New Product Development For Parkinson’s Disease And Neuroscience Education

PRESS RELEASE: GLNT Tackles Continuous Monitoring Of Essential Tremor With Launch Of Multi-Site Clinical Study

PRESS RELEASE: GLNT Begins Clinical Study To Demonstrate High Sensitivity Motor Symptom Detection In Parkinson’s Disease

PRESS RELEASE: GLNT Awarded Patent For Technology To Assess Parkinson’s Disease

PRESS RELEASE: Great Lakes NeuroTechnologies Receives Nearly $2 Million In New Funding To Expand Home-Based Technologies For Monitoring Movement Disorders

PRESS RELEASE: The University Of Rochester And Great Lakes NeuroTechnologies Launch New Clinical Study To Develop Ambulatory Dyskinesia Assessment System

PRESS RELEASE: Great Lakes NeuroTechnologies’ KinetiSense Technology Used In Parkinson’s Disease Gait And Balance Study

PRESS RELEASE: Great Lakes NeuroTech’s BioRadio And Vivonoetic Inc.’S VivoSense Used In Prematurity And Respiratory Outcomes Program Multicenter Study

PRESS RELEASE: Cleveland Medical Devices Inc. Spins Off Great Lakes NeuroTechnologies

PRESS RELEASE: CLEVEMED ASSISTS AMERICAN MEDICAL ASSOCIATION IN RELEASE OF CPT CODE FOR RECORDING PHYSIOLOGIC TREMOR

PRESS RELEASE: CLEVEMED ISSUES ONLINE UPDRS SCORING CHALLENGE TO HIGHLIGHT BENEFITS OF KINESIA™ AUTOMATED TREMOR SCORING

PRESS RELEASE: CLEVEMED LAUNCHES CLINICIAL STUDY MONITORING PARKINSON’S DISEASE MOTOR SYMPTOMS IN THE CLINIC AND AT HOME USING KINESIA™

PRESS RELEASE: CLEVEMED RECEIVES $1.23 MILLION IN NIH FUNDING TO DEVELOP A SYSTEM TO AUGMENT DEEP BRAIN STIMULATION PROGRAMMING IN PARKINSON´S DISEASE

PRESS RELEASE: FROST & SULLIVAN LAUDS CLEVEMED FOR KINESIA™, A REVOLUTIONARY MOBILITY DISORDER MONITORING SYSTEM

PRESS RELEASE: CLEVEMED’S KINESIA DEVICE AWARDED NEUROTECH BUSINESS REPORT’S “GOLD ELECTRODE AWARD” FOR BEST NEW PRODUCT

Press Release: CLEVEMED RECEIVES INC. 5000 AWARD FOR RECOGNITION AS ONE OF AMERICA’S FASTEST GROWING PRIVATE COMPANIES

Press Release: CLEVEMED PARTNERS WITH DATAWAVE TECHNOLOGIES® TO RELEASE BIOCAPTURE™ PRO, AN ADVANCED PHYSIOLOGICAL RESEARCH SYSTEM

Press Release: TWO CLEVEMED EMPLOYEES, CRAIG FREDERICK AND JOSEPH GIUFFRIDA, PHD, NAMED AS FINALISTS IN 2007 AMERICAN BUSINESS AWARDSSM

Press Release: CLEVEMED ANNOUNCES INTERNATIONAL LAUNCH OF NEW CLEVELABS™ LABORATORY COURSE SYSTEM FOR INTERNATIONAL MARKETS

Press Release: CLEVEMED ANNOUNCES THE RELEASE OF THE NEW BIOCAPTURE™ RESEARCH SYSTEM FOR INTERNATIONAL MARKETS

Press Release: CLEVEMED AWARDED $896,000 NIH GRANT TO HELP STROKE PATIENTS RECOVER LOST MOTOR FUNCTION

Press Release: CLEVEMED INTRODUCES CLEVELABS™ 6.0

PRESS RELEASE: CleveMed Launches A New Educational Device

Press Release: CLEVELAND MEDICAL DEVICES RECEIVES FDA CLEARANCE TO MARKET NEW WIRELESS EEG MONITORING TECHNOLOGY